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Glutamate-mediated damage to oligodendrocytes contributes to mental or physical impairment in periventricular leukomalacia (pre-or perinatal white matter injury leading to cerebral palsy), spinal cord injury, multiple sclerosis and stroke [1] [2] [3] [4] . Unlike neurons 5 , white matter oligodendrocytes reportedly lack NMDA (Nmethyl-D-aspartate) receptors 6, 7 . It is believed that glutamate damages oligodendrocytes, especially their precursor cells, by acting on calcium-permeable AMPA (a-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid)/kainate receptors alone [1] [2] [3] [4] or by reversing cystine-glutamate exchange and depriving cells of antioxidant protection 8 . Here we show that precursor, immature and mature oligodendrocytes in the white matter of the cerebellum and corpus callosum exhibit NMDA-evoked currents, mediated by receptors that are blocked only weakly by Mg 21 and that may contain NR1, NR2C and NR3 NMDA receptor subunits. NMDA receptors are present in the myelinating processes of oligodendrocytes, where the small intracellular space could lead to a large rise in intracellular ion concentration in response to NMDA receptor activation. Simulating ischaemia led to development of an inward current in oligodendrocytes, which was partly mediated by NMDA receptors. These results point to NMDA receptors of unusual subunit composition as a potential therapeutic target for preventing white matter damage in a variety of diseases.
Blocking AMPA/kainate receptors attenuates white matter injury in animal models of hypoxia/ischaemia 9, 10 , spinal cord injury 11, 12 and multiple sclerosis 13, 14 . However, NMDA receptors have been found in some cultured oligodendrocyte precursors 15 and in spinal grey (but not white) matter oligodendrocytes 16 , and NMDA receptor blockers have been shown to slow the loss of action potentials in white matter 10 and reduce damage to white matter in ischaemia 17 and in a model of multiple sclerosis 18 . We have therefore re-examined the involvement of NMDA receptors in the physiology and pathology of oligodendrocytes.
Whole-cell clamped precursor, immature and mature oligodendrocytes in white matter were distinguished by their morphology and antibody labelling 7, 19 ( Fig. 1a-c ). Precursor cells (Fig. 1a) had short processes not aligned with nearby axons, were labelled by antibodies against NG2 proteoglycan (see Methods for details regarding specificity), and often showed spontaneous synaptic currents (similar to grey matter oligodendrocyte precursors 20 ) that were blocked by tetrodotoxin (TTX; Fig. 1d ). Immature cells (Fig. 1b) had some processes aligned with adjacent axons, and were labelled by an antibody against O4 lipid sulphatide. Mature cells (Fig. 1c) had most of their processes aligned with axons, and were labelled by an antibody against myelin basic protein (MBP). Oligodendrocyte membrane resistance decreased with maturity (Fig. 1e) . The resting potential was approximately 260 mV (257.5^2.9 mV in 37 mature cells; without shunting by the electrode seal it would be ,4 mV more negative).
Precursor, immature and mature cerebellar white matter oligodendrocytes responded to glutamate (100 mM) with an inward current at 263 mV, which was unaffected by application of 1 mM TTX (P ¼ 0.4; Fig. 1f -h and Supplementary Fig. 1) , showing that axonal action potentials generated by glutamate depolarizing neurons did not contribute to the current (for example, by releasing K þ ). The current was potentiated when the local glutamate concentration was raised by blocking glutamate transporters with TBOA (threo-bbenzyloxyaspartate, P ¼ 0.016; Fig. 1g and Supplementary Fig. 1 ). The NMDA receptor antagonists D-AP5 (D(-)-2-amino-5-phosphonovaleric acid) and MK801, and the AMPA receptor antagonist NBQX (2,3-dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulphonamide) all reduced the glutamate-evoked current (Fig. 1h, i) , suggesting the presence of both NMDA and AMPA/ kainate receptors.
NMDA (60 mM) evoked an inward current in corpus callosum (Fig. 2a-c) and cerebellum (Fig. 2d, e) oligodendrocytes that was comparable in size (at 263 mV in 0 mM Mg 2þ ) to the current produced by AMPA (20 mM) or kainate (30 mM), and was larger than that produced by the metabotropic glutamate receptor agonist (1S,3R)-ACPD ((1S,3R)-1-aminocyclopentane-1,3-dicarboxylic acid; 100 mM). In cerebellar oligodendrocytes, the NMDA-evoked current was largest in mature cells ( Fig. 2f , P ¼ 0.042 compared with precursors) although the increased membrane area of mature cells may imply a lower current density.
The NMDA-evoked current ran down slightly with time ( Fig. 2g) , so current measurements in the presence of drug treatments were quantified relative to the average of control responses before and after drug application. The NMDA-evoked current was blocked by D-AP5 (Fig. 2h, j) but unaffected by TTX, NBQX or strychnine þ bicuculline (Fig. 2i, j) , and was not significantly affected (P ¼ 0.072) when glycine (100 mM, with 5 mM strychnine) was present, implying that the glycine-binding sites on these NMDA receptors are well-activated by endogenous glycine or D-serine. Changing from Mg 2þ -free superfusion solution to solution containing 2 mM Mg 2þ decreased the NMDA-evoked current at 263 mV three-to fivefold, independent of developmental age (Fig. 2k, l) . This decrease is much less than is found for most neurons 21 or for most cloned NMDA receptors 22 , which show a 60-fold reduction for receptors comprising NR1 and NR2A or NR2B subunits, and a 20-fold reduction for receptors comprising NR1 and NR2C or NR2D subunits, but is comparable to that seen for cloned receptors comprising NR1, NR2A and NR3A subunits 23 . Ifenprodil (10 mM), which blocks NR2B-containing NMDA receptors, had no effect on the NMDA-evoked current (Fig. 2j) . The current was also unaffected by pregnenolone sulphate (100 mM, which potentiates NR1/NR2A and NR1/NR2B receptors by 60-82% but inhibits NR1/NR2C and NR1/NR2D receptors by 32%), D-cycloserine (1 mM, with no added glycine, which potentiates NR1/NR2C receptors but inhibits NR1/NR2A and NR1/NR2B receptors) or D-serine (100 mM, with no glycine, which potentiates receptors lacking NR3 subunits but inhibits NR3-containing receptors) (Fig. 2j) . These results suggest either (1) the presence of a subunit (perhaps NR3) that suppresses modulatory actions on NR2 subunits, or (2) the presence of a combination of subunits that these agents modulate in opposite directions (for example, NR1/NR2A/NR2C or NR1/NR2/NR3), or (3) a mixture of receptors with different subunit combinations. Although the NMDA receptor subunit composition currently remains uncertain, it allows these receptors to generate a significant current even at the resting potential in a physiological extracellular Mg 2þ concentration. In precursor oligodendrocytes, the NMDA-evoked current reversed around 0 mV (Fig. 2m) , and in 2 mM Mg 2þ the currentvoltage (I-V) relationship showed a region of negative slope that was similar to, but less marked than, that produced by Mg 2þ -block of neuronal NMDA receptor channels. In mature oligodendrocytes, the I-V relationship often failed to reverse at positive potentials, which might reflect the NMDA receptors being electrotonically distant from the soma in the cell processes (see below), or NMDA receptor activation leading to Na þ entry and block of a K þ current in the cell 24 . Antibodies directed against NMDA receptor subunits labelled the myelinating processes, and some cell bodies, of oligodendrocytes in the cerebellar white matter. NR2C labelling ( Fig. 3a, b ) was abolished by omitting the primary antibody, or by preabsorption with the peptide to which it was raised ( Supplementary Fig. 2 ). Labelling was also seen for NR1 subunits, which colocalized with MBP in mature cells (data not shown), and for NR3 subunits (Fig. 3c, d and Supplementary Fig. 2 ). Weaker labelling was seen for NR2A, NR2B and NR2D, and was abolished by omitting the primary antibody (NR2A, NR2B and NR2D) or by peptide absorption (NR2D). Double-labelling showed colocalization of NR3 and NR2C subunits, and of NR1 and NR2C subunits in oligodendrocyte processes (Supplementary Figs 3, 4) . These data, together with the lack of ifenprodil-induced block and the weak Mg 2þ -block of the NMDA-evoked current, suggest that oligodendrocyte NMDA receptors contain at least NR1, NR2C and NR3 subunits.
Post-embedding electron microscopic immunochemistry showed that NR1 subunits were present in the myelinating processes of adult cerebellar oligodendrocytes (Fig. 3e, f and Supplementary Fig. 5 ), in the outer-and innermost membranes and also within the myelin (perhaps remaining from earlier in development). By quantifying the immunogold particles in the myelin and in the postsynaptic densities of mossy fibre-granule cell synapses ( Supplementary Fig. 5 ) and parallel fibre-Purkinje cell synapses, we found that the density of NMDA receptors throughout the myelin is as high as at the mossy fibre-granule cell synapse (Fig. 3g) . The density of particles in the outer membrane of the myelin (where the receptors may sense glutamate released from surrounding cells; 36.4^8.3 particles per mm 2 ) tended to be larger than that in the innermost membrane (where the receptors may sense glutamate released from the axon; 
17.7^4.3 particles per mm
2 , P ¼ 0.064), but both were similar to the average density measured over all of the myelin (33.6^4.5 particles per mm 2 ). To examine the role of oligodendrocyte NMDA receptors in pathological situations, we simulated 25 the energy deprivation that contributes to periventricular leukomalacia or that occurs after ischaemia in spinal cord injury. A solution simulating ischaemia evoked a slowly developing inward current in precursor and mature oligodendrocytes (Fig. 4 , peak inward current at 263 mVafter ,7 min was 307^83 pA and 280^48 pA in 7 precursor and 8 mature cells, respectively, in 2 mM Mg 2þ ). This current was generated partly by an increase in extracellular glutamate concentration, as it was reduced by D-AP5 and NBQX (Fig. 4a) . In some precursor oligodendrocytes (Fig. 4a, c) , the inward current early in ischaemia included an increased frequency of synaptic current-like events (Fig. 1d) (Fig. 2l) , but would be increased in unclamped cells by the ischaemia-evoked current depolarizing cells and reducing NMDA receptor Mg 2þ -block). The NMDA receptor-mediated current in precursor oligodendrocytes was on average 50% larger than that mediated by AMPA/ kainate receptors (Fig. 4b-d) , and in some cells comprised almost all of the current (Fig. 4c) . In mature oligodendrocytes, the fraction of the inward current that was generated by glutamate was smaller than in precursor cells (Fig. 4d) , suggesting that (as mature cells can generate larger glutamate-and NMDA-evoked currents; Figs 1f, 2f) less glutamate release occurs around mature cells during ischaemia. Further work is needed to establish the origin of the part of the inward current that is not generated by glutamate release.
Here we have shown that oligodendrocytes express functional NMDA receptors. The NMDA-evoked currents that we observe are unlikely to be produced by an agent released secondarily from neurons because they are unaffected by TTX or by block of AMPA/kainate, metabotropic glutamate receptors, GABA A or glycine receptors (Figs 1i, 2j) , and oligodendrocytes show no current in response to application of noradrenaline, dopamine, histamine, serotonin, ATP, adenosine or acetylcholine (data not shown). Antibody labelling ( Fig. 3) and the voltage-dependence of the current (Fig. 2m) show that oligodendrocytes themselves express NMDA receptors. Previous work that failed to detect NMDA receptor currents in oligodendrocytes was partly on cultured cells 6 , which may downregulate their NMDA receptor expression. Our data (Fig. 2a) contradict the absence of NMDA responses reported in corpus callosum oligodendrocytes 7 . As oligodendrocyte NMDA receptor currents occur in both the cerebellum and corpus callosum (Fig. 2) , they may represent a general property of white matter oligodendrocytes. Our electrophysiological recordings are from precursor, immature and mature oligodendrocytes in postnatal day (P)7-14 rats, and remain to be extended to the adult; however, NMDA receptor subunits are also present in adult oligodendrocytes (Fig. 3e) .
Oligodendrocyte NMDA receptors are likely to have a role in controlling oligodendrocyte development and myelination 26 , and in damaging oligodendrocytes under pathological conditions. They show only weak block by Mg 2þ at the cells' resting potential 16 ( Fig. 2l) , and mediate part of the inward current generated in oligodendrocytes in response to simulation of the energy deprivation that occurs in periventricular leukomalacia, in stroke, and after ischaemia in spinal cord injury. Notably, NMDA receptors are present in the myelinating processes of oligodendrocytes, where the intracellular volume is small and receptor-mediated ion influx may produce large increases in intracellular ion concentration and osmotic water flux, which could disrupt myelination. The higher glutamate affinity of NMDA receptors relative to AMPA receptors makes them more likely to be activated in neurodegenerative disorders that involve a small but prolonged increase in extracellular glutamate concentration, as can occur in multiple sclerosis. Thus, oligodendrocyte NMDA receptors could contribute to causing the white matter damage that occurs when the extracellular glutamate concentration is increased in periventricular leukomalacia, spinal cord injury, multiple sclerosis and stroke [1] [2] [3] [4] . Indeed, in the optic nerve, activation of NMDA receptors on oligodendrocyte processes when glutamate is released during ischaemia leads to the disintegration of those processes 27 . The unusual subunit combination of these receptors, which may contain NR1, NR2C and NR3 subunits, suggests that they might be a useful therapeutic target in a variety of brain disorders.
METHODS
Brain slices. Cerebellar or forebrain slices (225-mm thick) were prepared from P7-14 rats in solution containing 1 mM sodium kynurenate to block glutamate receptors. The cerebellum myelinates relatively late, facilitating investigation of different developmental stages. The corpus callosum is an area that becomes thinned in severe periventricular leukomalacia. Slices were superfused at 33^1 8C with bicarbonate-buffered solution (for ischaemia experiments) containing 126 mM NaCl, 24 mM NaHCO 3 , 1 mM NaH 2 PO4, 2.5 mM KCl, 2 mM MgCl 2 , 2.5 mM CaCl 2 , 10 mM glucose, 0.1 mM glycine (which activates the NMDA receptor glycine-binding site) and 0.005 mM strychnine (which blocks glycine receptors), bubbled with 95% O 2 , 5% CO 2 (pH 7.4); or at 24^1 8C with HEPES-buffered solution (for non-ischaemia experiments) containing 144 mM NaCl, 2.5 mM KCl, 2 mM MgCl 2 , 10 mM HEPES, 1 mM NaH 2 PO 4 , 2.5 mM CaCl 2 , 10 mM glucose, 0.1 mM glycine and 0.005 mM strychnine, with the pH set to 7.4 using NaOH. Omitting glycine or adding D-serine did not affect the NMDA receptor current (see text).
To simulate ischaemia, we replaced external O 2 with N 2 , and external glucose with 7 mM sucrose, added 2 mM iodoacetate to block glycolysis, and added 100 mM rotenone or 25 mM antimycin to block oxidative phosphorylation 25 . Without iodoacetate and rotenone/antimycin, it took ,3-fold longer for the ischaemia-evoked inward current to develop, probably because in an open chamber O 2 can diffuse to the slice, allowing glycogen metabolism in mitochondria for longer than would occur in vivo 25 . Recording and cell identification. White matter cells (avoiding cerebellar nuclei) were whole-cell clamped with pipettes containing a K þ -based solution (for glutamate application) consisting of 130 mM KCl, 4 mM NaCl, 0.5 mM CaCl 2 , 10 mM HEPES, 10 mM EGTA, 2 mM MgATP, 0.5 mM Na 2 GTP, 2 mM K-Lucifer yellow, pH 7.2 (adjusted with KOH), or a Cs þ -based solution (for NMDA application and ischaemia) consisting of 130 mM CsCl, 4 mM NaCl, 0.5 mM CaCl 2 , 10 mM HEPES, 10 mM BAPTA, 2 mM MgATP, 0.5 mM Na 2 GTP, 2 mM K-Lucifer yellow, pH 7.2 (adjusted with CsOH). Series resistance was 8-20 MQ, before 60% compensation.
Cells were identified on the basis of post-recording dye-fill morphology and antibody labelling. NG2 antibody labelled 15 out of 15 tested cells with precursor morphology. (We take NG2 labelling to indicate oligodendrocyte precursors 20 . However, some NG2 cells may be a glial class distinct from oligodendrocytes 28 , or (in grey matter) neuronal precursors 29 . Showing that oligodendrocytes express NMDA receptors does not depend on recording precursor cells, as NMDA receptor currents were also seen in immature and mature cells.) O4 antibody labelled 6 out of 6 cells with immature morphology. MBP antibody labelled all 17 cells with mature morphology that were tested. Antibody against the oligodendrocyte transcription factor Olig2 labelled all ten cells tested (seven precursors, one immature and two mature cells). Oligodendrocytes could be distinguished from astrocytes, which showed gap junction coupling (as revealed by Lucifer yellow spreading to other cells and GFAP labelling; 5 out of 5 cells). Electrode junction potentials were compensated. I-V relations were from responses to 200-ms voltage steps. Immunocytochemistry. Antibody labelling and post-embedding electron microscopic immunocytochemistry are described in the Supplementary Material. Statistics. Data are presented as mean^s.e.m. P values are from Student's twotailed t-tests except for multiple comparisons, which were done using one-way analysis of variance (ANOVA) and Tukey's post-hoc tests.
